STAT3 and neoplasm: Despite this discrepancy, the negative effect of STAT3 activation on the expression of MHC class II and costimulatory molecules, such as CD80 or CD86, is well established by studies in tumor-associated DCs and other antigen presenting cells (APCs) [31,32,33,34].